| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |